Vaccination with tumor-loaded dendritic cells (DC) is a promising treatment strategy for patients with renal cell carcinoma (RCC). Cells undergoing cell death proved useful as a source of tumor antigen for DC loading. Both apoptotic and necrotic tumor cells have been shown to efficiently load RCCtumor antigens on DC. However, no direct comparison of these two kinds of death has been attempted in the same RCC. We compared DC pulsed with apoptotic cells, whole celllysates or their supernatants of the cell line Kl, derived from a patient with clear cell RCC, to determine their ability to activate T cells. Monocyte-derived DCs were pulsed with the different sources of tumor antigen, matured and cocultured with autologouos peripheral blood lymphocytes. After three weekly re-stimulations with DCs, generation of cytotoxic T lymphocytes CTL was assessed by IFN-y release in an ELlSpot assay in the presence of the sensitizing target. By comparison with lysate, apoptotic tumor cells induced a higher frequency of MHC class I-restricted IFN-y releasing lymphocytes. A higher CTL response was induced by pulsing DCs with cell lysate supernatant compared with whole cell lysate. These results indicate that, although necrotic death has been regarded as highly permissive when compared to apoptotic death, the immunogenicity of the death treatment may vary from one tumor to another.
Renal cell carcinoma (RCC) is resistant to conventional therapies such as radiation, hormone and chemotherapy (1-2). Frequent infiltration of RCC tissues with cells of the immune system as well as rare spontaneous regressions and clinical responses to cytokine therapy have suggested that RCC is immunogenic and therefore open to active immunotherapy (3) (4) (5) .
The discovery of tumor associated antigens (TA) (6-7) has both given force to the concept of immune surveillance and provided a valuable therapeutic tool to target and destroy cells that resist surgical and chemical interventions. Since tumor antigens are allegedly weak or tolerant antigens that have already escaped tumor immune surveillance, the challenge is to present these antigens in a way such as to break the immune surveillance.
Dendritic cells (DC), the most potent antigen presenting cells, capture tumor cells and after intracellular processing present the relevant T-cell antigen epitope in the context of both class I and class II MHC, thus priming CD4 and crosspriming CD8 T lymphocytes. After capturing the antigen in vivo, dermal or circulating immature (i)DC down-regulate phagocytosis, up-regulate the expression of MHC and other molecules relevant to the antigen presentation process and migrate to the lymph nodes where they prime T cells (8) (9) . Vaccination with antigen-loaded DC has shown promise in RCC (10) (11) (12) (13) (14) (15) and other tumor systems (16) . Tumor cells undergoing cell death have proved useful as a source of tumor antigens for DC loading. The kind of death can influence the access of TA to the DC cross-presentation pathway. Necrotic death is perceived by the immune system in the context of a danger signal and induces a reactive response (17) . However, controversy exists as to whether necrotic or apoptotic tumor cells or other sources of tumor antigens are most advantageous in stimulating tumor-reactive T cells (18) (19) (20) (21) (22) (23) (24) (25) . In RCC, irradiated tumor cells and cell Iysates have been employed to load DC (10) (11) (12) (13) . However, direct comparison of necrosis and apoptosis on the same cell line has only been attempted in mice (24) (25) .
Here we compare DC pulsed with apoptotic cells or cell lysates of the cell line KI, derived from a patient with clear cell RCC, to determine their ability to activate T cells.
MATERIALS AND METHODS

Cytokines
Human recombinant granulocyte-macrophage colony stimulating factor (GM-CSF) was purchased from Sigma-Aldrich; IL-4, TNF-u and IL-7 were purchased from Preprotech, IL-2 from Chiron (Milan, Italy) and PGE 2 from CaymanChemical Company (lnalco, Milan, Italy).
Antibodies
The following mAbs were used for cytofluorimetric analysis: FITC-conjugated anti-CDl4 (Caltag, Valter Occhiena, Torino, Italy); PE-conjugated anti-CD80 (Beckton Dickinson, Mountain View, CA), anti-CD40 (Beckton Dickinson), anti-HLA-DR and anti-HLA-ABC (Dako, Milan, Italy). Isotype-matched irrelevant mAbs were also from Dako. The anti-MHC class I blocking mAb W6/32 was from Serotec, DBA Italia s.r.I. (Milan, Italy).
Phenotype ofdendritic cells
Cells were collected, washed in PBS and incubated (10 5 cells in 100 III PBS) for 30 min at 4°C with 10 III of the above mAbs. After washing, the cells were fixed in PBS-I% paraformaldehyde and analyzed using a FACSCalibur (Becton Dickinson). A total of 10,000 events were analyzed for each sample.
Tumor cells
The clear cell RCC cell line KI (established by G.c.) was grown as suspension culture in RPMI 1640 (Sigma-Aldrich), 10 % heat-inactivated FCS (Life Technologies Ltd, Paisley, Scotland) and I ug/rnl L-glutamine (complete medium, CM) and subcultured every 2-3 days. The adherent cells were detached by gently scraping for flow cytometric analysis or by trypsin treatment for use in culture.
Proliferation assay (mixed lymphocyte reaction. MLR)
A constant number (5 x 10 5 ) of allogeneic non-adherent peripheral blood mononuclear cells (PBMC), were incubated with graded numbers of irradiated (3000 rads IJ7Cs source) DC. Experiments were performed in 96-well cell culture plates in RPM1-I640 medium supplemented with 10% FCS. To test the extent of DNA synthesis, day 4 cultures were admixed 21lCi/mi of [methyPH]-TdR (5 Ci/mM specific activity) (NEN-Dupont, Milan, Italy) 16 h before harvesting onto glass fibre filters. 3H-TdR uptake was evaluated bỹ -scintillation counting and expressed as cpm/l O" cells. Stimulation index was calculated as the ratio between count per minute (cpm) of lymphocytes-DC mixed cultures and cpm of lymphocytes alone.
Generation ofDC
Generation of DC from adherent PBMC was performed as described previously (26) (27) (28) . Briefly, PBMC were isolated from heparinized blood of blood bank donors by standard Ficoll-Hypaque (Sigma-Aldrich) density gradient centrifugation, washed with RPMI supplemented with 5 mM EDTA and 2% heat inactivated FCS and suspended at 5x 10 6/ml in CM. After a 2 h incubation at 37°C in a 5% CO 2 incubator, non-adherent cells were removed with pre-warmed (37°C) CM and kept frozen as a source of peripheral blood lymphocytes (PBL). The adherent cells were cultured in the above CM supplemented with GM-CSF (100 ng/ml) and IL-4 (10 ng/ml). Cytokine-enriched medium was replaced on day 3 and iDC were collected on day 6.
Killing oftumor cells K I RCC (I 06/ml in CM) were irradiated (12,000 rads or 120 Gy) to induce apoptotic death or subject to four freezing (-20°C, 30 min)/thawing (37°C, 30 min) cycles to induce necrotic death. An aliquote of the whole lysate (WL) was centrifuged at 12,000 rpm for 10 min and the supernatant was collected (SL). Protein concentration of the WL and SL was determined using the Bio-Rad Protein assay (Bio-Rad Laboratories, Munchen, Germany).
Analysis oftumor death
After 4 h from the exposure to radiation, tumor cells were stained with AnnexinV (AnnV)-FITC and propidium iodide (PI) using the Apopt-test kit (Dako), followed by flow cytometric analysis. Viabilitycount was done by Trypan Blue (Sigma-Aldrich) dye exclusion after each cycle.
Uptake of dying tumors by iDC
Phagocytosis of tumor cells by iDC was verified by using flow cytometry. K I cells were green labeled with the PKH2 aliphatic green fluorochrome (Sigma-Aldrich) according to the manufacture's instructions, before receiving the above killing treatments. Four hours after y-irradiaton, apoptotic K I cells were washed (two centrifugations of 10 min at 300 g) and added at the I: I ratio to iDe. WL and SL were added to DC at 150 ug/ml (optimal concentration derived from pilot experiments) and incubation was carried out for 24 h at 37°e. The DC-KI 1RR , DC-Kl w L and DC-Kl sL mixed cultures were stained with the PE mAb CD80 (20 min at 4°C). Engulfment of tumor cells by DC was assessed by flow cytometric analysis as the percentage of double-stained vs PE-positve (red) cells on a total of 10,000 events.
Cross-priming of lymphocytes with tumor-loaded autologous DC
Twenty-four hours after the indicated treatments, K I cells were mixed with DCs at a ratio of I: I and the incubation proceeded for another 24 h in GM-CSF and IL-4-containing medium. After a further 48 h incubation with TNF-a and PGE 2 , mature (m)DCtumor mixed cultures were irradiated (12,000 rads) and added to autologous T lymphocytes at a ratio of I: 15. IL-2 (20 V/ml) was added to the cultures after 24 h and the procedure was repeated weekly, for up to 3 total stimulations. Generation of specific anti-tumor response was evaluated 5 days after the last stimulation as MHC class I-restricted IFN-y release.
ELISpot
The frequency of IFN-y-secreting T lymphocytes in cultures was assessed in an ELISpot assay, as previously described (27) (28) . Briefly, nitrocellulose membrane 96-well microtiter plates (Multiscreen, Millipore, Vimodrome, Milan, Italy) were coated with anti-IFNy mAb (BD PharMingen, Mountain View, CA) and incubated overnight at 4°e. The remaining binding sites were blocked by incubation with 10% FCS. After extensive washings, Ixl0 5 T cells (initial number in culture) were seeded in medium alone, medium containing phorbol myristate acetate (PMA) (50 ng/ml) and ionomycin (I ug/rnl) or medium containing the sensitising target DC-Kl w L or unloaded De. Targets were pre-incubated for 20 min at 4°C with I mg/ml of the anti-human MHC class I blocking mAb W6/32 or isotype-matched Abs and added to lymphocytes at a 2: I ratio. After 24 h, cells were washed and a biotinylated anti-IFN-y mAb (BD PharMingen) was added. After I h incubation, plates were washed with PBS-Tween20 and avidin-horse radish peroxidase-conjugated (BD PharMingen) was added for 30 min. Following another PBS-Tween20 washing, the substrate solution (3-amino-9-ethylcarbazole) (Sigma-Aldrich) was added for 30 min. The reaction was stopped by rinsing with tap water. After the plates had dried overnight, red spots (indicative of reactive lymphocytes) were enumerated by computer-assisted video image analysis (CVIA) with the AID ELISpot-Reader (Bioline Amplimedical, Milan, Italy).
Statistical analysis
Statistical significance of the treatments was calculated using the Student's t-test for parametric data (percent double stained cells) and the Wilcoxon test for non-parametric data (ELISpot assays).
RESULTS
Modulation of membrane and functional characteristics of control unloaded DC
DC were produced as indicated in Materials and Methods and their ability to modulate membrane and functional features as they progressed from monocytes to iOC and then to mOC was assessed ( Fig. lA) . As expected, the CO 14 antigen was expressed by all monocytes and completely disappeared starting from iDe. Very few cells were positive for C040 and C080 in the monocyte population, but their percentage increased in iDC and reached complete expression in mOe. MHC class II antigens increased as iOC developed to mOe. Changes in the alloantigen presentation was separately assessed in monocytes vs iOC and in iOC vs mOC (Fig. 1B) . Mean±SD ofthree MLR experiments with blood of different donors show increased stimulation index and an optimal antigen presenting activity for mOC at the 20:1 responder: stimulator ratio.
Characteristic of tumor cells receiving different treatments
A single freezing-thawing course induced the 
10'
.Ann V
Fig. 2. Death treatments induced homogenous necrotic and apoptotic tumor populations. (A), freezing-thawing induces prompt massive necrotic death in Kl cells, as judged by Blue Trypan dye exclusion. (B) Ann VIPI-coupledflow cytometric analysis shows that most ofKl cells are in apoptosis (AnnV+/PI) 4 h after irradiation (12,000 rads) (representative data from one ofthree experiments).
primary necrosis of Kl cells ( Fig. 2A) , while most of them were in apoptosis 4 h after irradiation, as assessed by AnnV and PI staining (Fig. 2B) .
Uptake ofapoptotic tumor by iDes
To determine the ability of iDCs to capture whole apoptotic tumor, Kl cells were stained with PKH2 before receiving the apoptotic treatment and cultured with equal numbers of CD80-stained DCs. In Fig. 3A-C to its sensitivity to anti-MHC class I mAb (Fig. 58) .
that oflive cells (38). 
Maturation of iDC induced by uptake ofdifferent components ofnecrotic tumor
Engulfment of apoptotic Kl cells did not induce overexpression of the CD80 antigen (not shown). Exposure of iDC to necrotic K 1 cells induced a different pattern of maturation, depending on the form of the necrotic material. While whole cell lysate was ineffective, the soluble components contained in the supernatant produced an increase of the CDI4' MHC W DC cell fraction (Fig 4. means ±SD from two donors).
DISCUSSION
For the purpose of clinical cancer trials, DC can be loaded with appropriate antigens by different strategies. One is to load DC with material from apoptotic or necrotic tumor cells (16) . Apoptosis occurring under physiological conditions is considered to be tolerogenic, in contrast with necrosis, which is perceived as threatening and is therefore highly immunogenic. However, recent data indicate that apoptosis induced by exogenous agents may also be immunogenic in vivo (29) . RCC vaccination protocols mainly employ tumor lysate to load DC (10) (11) (12) (13) . The present study compares the immunogenicity of apoptosis vs necrosis in a single (Kl) RCC cell line.
Since Kl cells are HLA-A2-negative, lymphocyte-autologous DC loaded with Kl cell lysate instead ofKl cells themselves were employed as targets ofCTL activity. Even under these stringent conditions (30) , cross-priming of CTL was clearly much more effective when DC were loaded with yirradiated K 1 cells than with K1 cell lysates, and the lysate supernatant was superior to the whole lysate.
Appropriate conditions were chosen to allow unambiguous evaluation of the role of apoptotic death on DC activation. Four hours after irradiation massive apoptosis with virtually no signs of secondary necrosis was evident. The higher crosspresentation activity by DC loaded with apoptotic tumor indicates that this kind of death favors the delivery of tumor-associated antigens to DC. Increased cross-presentation of RCC-derived antigens, in fact, was accompanied by increased internalization of the apoptotic tumor by DC. More avid DC internalization of irradiation-and doxorubicin-induced apoptotic tumors has recently been demonstrated (29) .
The idea that the cell death induced by chemotherapeuticals and radiotherapy may be immunogenic is very intriguing (31) . Iatrogenic tumor death can, indeed, generate a formidable source of antigens for DC loading and crosspresentation in vivo. Due to the massive apoptotic products, physiological internalization can be delayed allowing for the formation of secondary ,DC·K1WL iDC·K1SL iO C 90 IFN-y production by PBMCs cocultured with tumor antigen-loaded DCs iDCs were pulsed with K I'RR' K 1WL or K1SL and matured in the presence of TNF-a and PGE r After 24 h, mDCs expressed high levels of co-stimulatory molecules and maturation markers (Fig. 1) . mDC were co-cultured with autologous P8L at a ratio of 1:15 in the presence oflL-2 and IL-7, and new DCs were added every 7 days. Five days after the third stimulation, the frequency of CTL in each culture was evaluated as the percentage of IFN-y releasing cells against the sensitizing target (Fig. 5 ). The highest CTL response was found when K I'RR were used as the source of antigen with no significant difference between Kl wL and Kl sL (Fig. 5A ). IFN-y release was primarily attributable to CD8 CTL, due necrotic tumors and release of pro-inflammatory mediators. This situation, however, does not apply to our in vitro system, where molecular events associated with apoptosis may explain the increased efficiency of DC cross-presentation. Modulation of the peptide repertoire and enhanced MHC Class I expression after irradiation has been shown in vitro (32) . This, however, is not a general rule. In our previous studies, dying gastrointestinal primary cells induced a higher CTL response in an autologus setting when loaded on DC as lysates than as apoptotic bodies (26, 30) . In one of those studies, the amount ofhsp70 in the tumor cell lysate did not correlate with the CTL response (30) . In separate studies using a gastric carcinoma cell line, we observed a strict correlation between secondary necrotic-associated hsp70 production and the ability to efficiently load DC (27) (28) . It must therefore be concluded that both the kind of cell death and the molecules up-regulated in a given cell type influence the immunogenic outcome of DC loading. Our data show that development of MHC 1unrestricted IFN-y release was evident in cultures stimulated by irradiated K I-loaded DC, indicating that NK cells were also involved in the response. The NK cells are effectors ofthe innate arm ofthe immune defense and kill tumor cells in an antigen-unspecific manner. In our experiments, apoptotic tumor cells were present in co-cultures of lymphocytes with apoptotic tumor cell-pulsed DCs. This was not the case in the co-cultures with supematant-or lysatepulsed DCs, because excess antigen was removed by washing. Therefore, it seems likely that contact of tumor cells with NK cells within the lymphocyte population played a role in NK cell activation. The fact that the Kl cell line did not express MICA (data not shown), one of the ligands of the NKG2D NK activating receptor family (33) , indicates that other NK-activating receptors may be involved.
Together, the present findings indicate that, even though necrosis has been regarded as highly permissive when compared to apoptosis, the ideal death treatment may vary from one tumor to another. Our illustration of the increased immunogenicity of an apoptotic tumor is in line with the current combinations of chemotherapy/radiotherapy with immunotherapy (34) . In addition, it confirms that antigen preparation is a critical determinant in the induction of antitumor immunity and offers a key to improve ex-vivo RCC antigen loading of DC.
